Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Doesn't include medipets or meds biotech either, or vending machines, kiosks and what else are we forgetting?
Now let's see some earnings!!!!
Nice close at 16.88 on almost 9 million volume.
I agree that CVSI (last year) is a good example for comparison of the potential for the share price of POTN to grow because they had SEC problems, debt to resolve and similar but lower revenues.
Shall we have a $2 (millionaire) party in Ft Lauderdale?
And then you predict a new low- based on a stellar earnings report?
I still can't believe we are below .30, ridiculous!
Looks like some big buys in hundred thousands. Wonder why?
Give POTN one more week.
Futures are up and Aurora posted great numbers yesterday, which should elevate the sector.
I agree, sure would like to see some great numbers today. There was a discussion recently about how they have been releasing news at 8:15 to 830 lately....
Why do you assume no fins released today?
Aurora can have my shares for $8
Aurora had a huge increase in revs reported today. CGC and Tilray reporting in the next few days. This is a huge week for the cannabis sector. I suspect that many are watching for POTN earnings tomorrow.
http://www.msn.com/en-us/money/companies/coming-to-a-mall-near-you-cbd-shops/ar-BBTsBaf?ocid=ientp
If you are selling one of the top CBD retailers just before earnings...
I would also hope to get a projection of 2019 revenues and a break out of revenue from each subsidiary.
Four more days to release them this week. Sure hope it's this week, it's been a looooong wait.
If revenue growth is high enough and the company expenditures on marketing and increased production are generating that growth and keeping them in front of the competition, higher multiples are merited.
More like this year- IMO revenue can increase 50-100% over 2017.
I would be happy with unaudited Q4 while waiting for completion of audit for SEC and uplist.
Anybody here have pacer access- can you check for court filing updates?
POTN has not made any statements about when earnings will be reported, but didn't they have the first 3 quarters audited already for the most recent SEC registration?
I am talking about last year, 2017, reported on Jan 24, 2018. We are expecting Q4 2018 this week.
Last year was reported Jan 24. TD Ameritrade has Feb 11 listed for earnings, so expect to see the report this week.
Two relevant numbers- last year's revs at least 24 million and current market cap 74 million. Going through other stocks in the sector for comparison, POTN is very undervalued. Earnings expected this week and I am expecting blastoff.
I agree, 10 bagger after uncertainty is put to rest.
The chart will be irrelevant after audited earnings are released and we are SEC registered.
Some PRs are starting to trickle out
https://finance.yahoo.com/news/4-marijuana-stocks-could-test-171000351.html
We have used relax and chill gummies for anxiety and insomnia, and high concentration CBD oil and cream for topical treatment of arthritic and injured knee pain. Others on this board like WTC and Loot have more knowledge and experience with products for pain. I will also say that I would recommend the meds biotech products (pills) with curcumin for cancer and inflammation. Curcumin is almost a miracle cure for inhibiting arthritis and cancer growth.
There is a classification called GRAS, generally recognized as safe, that says that food components or natural compounds being sold on the market already will not require clinical safety data. I think that CBD products will not be removed or slapped with additional rules if clearly labeled as containing CBD- but- the FDA is cracking down on therapeutic claims that are not backed by clinical trials. Goulding and POTN have been very careful about this, and are planning clinical trials for claims they want to make. It is interesting to me that the FDA is more concerned about restaurant foods and beverages with CBD, maybe they are concerned that the CBD is not measured, labeled and controlled for underage kids. The DEA would have to reschedule CBD, and they are VERY slow to do this for anything.
Excellent info! Could a moderator sticky this? This is DD that is hard to come by. I especially appreciate that you are in Oregon, where the market is more mature and competition much stiffer.
Agree with you on the uncertainty surrounding the SEC reg withdrawals and the new CEO, but IMO the rewards outweigh the risks and the uncertainty will soon be over with upcoming earnings report and SE registration.
That is a major plus for FRLF, just can't tell what the timing is for the next leg up and increase in shareholder value.
After the upcoming run to .97, I plan to take some off table myself (or I might wait and see if we hit 1.5 this time within a short time frame). That said, I run a preclinical research lab on therapeutic, natural plant-based compounds with testing on human cells and in clinical trials and I can tell you that it is a fact that some of these are very potent treatments for diabetes, pain, obesity, other inflammatory diseases and cancer (curcumin being one of the best IMO). I and my family members with pain and anxiety have tried Diamond products and they are excellent. This company is the real thing in an exploding market- this is the tip of the iceberg, not just a short-term pump. POTN will increase in value very soon, some of the others will take longer IMO.
As sad as your story is (and I feel for you) fair value for this company with a premium brand in an exploding market in its infancy is at least a conservative market cap of 8X last years revs, is .50 minimum. So I'll check back with you in a month after 4Q earnings SEC registration and uplist application.
We are up over 7% so far on good volume, hope the interest continues into earnings next week.
FRLF is competing with BIG rivals for production, even the CGCs and Aphrias will be fighting for their share. Any insights here about how FRLF can win this competition?
Exactly what I was thinking. The common pattern was several big days up, a day pull back, then the next big leg up. Patience pays off, nervous day traders can get burned trying to predict daily moves. Huge catalysts will drive the POTN shatre price up over the next several quarters IMO.
It's very simple to understand that DiamondCBD has some of the most high quality well-known CBD products in this rapidly growing industry and is at the front of the race for marketing and branding. Earnings will easily lift POTN to dollars this year IMO. Personally, it's hard for me to see how or when your fave stock is going to blow out revenues any time soon although I am a leafer also (to a small extent).
I have a feeling we will get revenues tomorrow. Either way, IMO you will never see .15 again after revenues, SEC reg, and uplist.